252 related articles for article (PubMed ID: 32609057)
21. The role of nanoparticles in the improvement of systemic anticancer drug delivery.
Field LD; Nag OK; Sangtani A; Burns KE; Delehanty JB
Ther Deliv; 2018 Jul; 9(7):527-545. PubMed ID: 29943689
[TBL] [Abstract][Full Text] [Related]
22. An update on liposomes in drug delivery: a patent review (2014-2018).
El-Hammadi MM; Arias JL
Expert Opin Ther Pat; 2019 Nov; 29(11):891-907. PubMed ID: 31603360
[No Abstract] [Full Text] [Related]
23. OX40 agonists for cancer treatment: a patent review.
Cebada J; Perez-Santos M; Bandala C; Lara-Padilla E; Herrera-Camacho I; Rosas-Murrieta NH; Millán-Pérez Peña L; Monjaraz E; Flores A; Anaya-Ruiz M
Expert Opin Ther Pat; 2021 Jan; 31(1):81-90. PubMed ID: 32945223
[TBL] [Abstract][Full Text] [Related]
24. Lipoproteins for therapeutic delivery: recent advances and future opportunities.
Raut S; Dasseux JL; Sabnis NA; Mooberry L; Lacko A
Ther Deliv; 2018 Mar; 9(4):257-268. PubMed ID: 29495929
[TBL] [Abstract][Full Text] [Related]
25. Recent Patents on Heat Shock Proteins Targeting Antibodies.
Fernandes JC; Alves P
Recent Pat Anticancer Drug Discov; 2017; 12(1):48-54. PubMed ID: 27881057
[TBL] [Abstract][Full Text] [Related]
26. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
27. LAG-3 antagonists by cancer treatment: a patent review.
Perez-Santos M; Anaya-Ruiz M; Cebada J; Bandala C; Landeta G; Martínez-Morales P; Villa-Ruano N
Expert Opin Ther Pat; 2019 Aug; 29(8):643-651. PubMed ID: 31291131
[No Abstract] [Full Text] [Related]
28. Mathematical modelling of liposomal drug release to tumour.
Chakravarty K; Dalal DC
Math Biosci; 2018 Dec; 306():82-96. PubMed ID: 30391313
[TBL] [Abstract][Full Text] [Related]
29. Tumor cell targeting of liposome-entrapped drugs with phospholipid-anchored folic acid-PEG conjugates.
Gabizon A; Shmeeda H; Horowitz AT; Zalipsky S
Adv Drug Deliv Rev; 2004 Apr; 56(8):1177-92. PubMed ID: 15094214
[TBL] [Abstract][Full Text] [Related]
30. [Specificities of patent protection in the pharmaceutical industry: modalities and traits of intellectual property].
Jannuzzi AH; Vasconcellos AG; de Souza CG
Cad Saude Publica; 2008 Jun; 24(6):1205-18. PubMed ID: 18545747
[TBL] [Abstract][Full Text] [Related]
31. Advanced strategies in liposomal cancer therapy: problems and prospects of active and tumor specific drug release.
Andresen TL; Jensen SS; Jørgensen K
Prog Lipid Res; 2005 Jan; 44(1):68-97. PubMed ID: 15748655
[TBL] [Abstract][Full Text] [Related]
32. Liposomal Nanostructures for Drug Delivery in Gastrointestinal Cancers.
Das M; Huang L
J Pharmacol Exp Ther; 2019 Sep; 370(3):647-656. PubMed ID: 30541917
[TBL] [Abstract][Full Text] [Related]
33. Recent advances in therapeutics and drug delivery for the treatment of inner ear diseases: a patent review (2011-2015).
Nguyen K; Kempfle JS; Jung DH; McKenna CE
Expert Opin Ther Pat; 2017 Feb; 27(2):191-202. PubMed ID: 27855527
[TBL] [Abstract][Full Text] [Related]
34. Nanotechnology and Protection of Intellectual Property: Emerging Trends.
Siri JGS; Fernando CAN; De Silva SNT
Recent Pat Nanotechnol; 2020; 14(4):307-327. PubMed ID: 32532198
[TBL] [Abstract][Full Text] [Related]
35. Liposomes in drug delivery: a patent review (2007 - present).
Arias JL
Expert Opin Ther Pat; 2013 Nov; 23(11):1399-414. PubMed ID: 23957267
[TBL] [Abstract][Full Text] [Related]
36. Colloidal systems for tumor targeting.
Storm G; Crommelin DJ
Hybridoma; 1997 Feb; 16(1):119-25. PubMed ID: 9085138
[TBL] [Abstract][Full Text] [Related]
37. An overview of a recent court challenge to the protection of biomarkers as intellectual property.
Hall SC; Tromp JM; Jortani SA
Clin Chim Acta; 2011 May; 412(11-12):802-5. PubMed ID: 21315704
[TBL] [Abstract][Full Text] [Related]
38. Exploring the impact of physicochemical properties of liposomal formulations on their in vivo fate.
Sheikholeslami B; Lam NW; Dua K; Haghi M
Life Sci; 2022 Jul; 300():120574. PubMed ID: 35469915
[TBL] [Abstract][Full Text] [Related]
39. Application of liposomal technologies for delivery of platinum analogs in oncology.
Liu D; He C; Wang AZ; Lin W
Int J Nanomedicine; 2013; 8():3309-19. PubMed ID: 24023517
[TBL] [Abstract][Full Text] [Related]
40. Liposomal drug delivery systems: an update review.
Samad A; Sultana Y; Aqil M
Curr Drug Deliv; 2007 Oct; 4(4):297-305. PubMed ID: 17979650
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
